The 15th Annual Arthur H. Briggs Lectureship, sponsored by the Department of Pharmacology, will be held at 4:00 p.m. on Monday, September 22, 2008 in room 309L. Dr. Tomas Hökfelt will be the featured speaker and will present Three decades with three 'Swedish' neuropeptides: Substance P, galanin and NPY in pain and depression. A wine and cheese reception will follow the lecture and all are invited to attend.

Dr. Hökfelt is Professor Emeritus of Histology and Cell Biology at the Karolinska Institute in Stockholm, Sweden. He received his Ph.D. in 1968 and his M.D. in 1971. In 1990, Dr. Hökfelt was conferred in honorary membership in the American Physiological Society (APS). At that time, as one of only 29 honorary members, the APS described him as one of the fathers of what is sometimes called chemical neuroanatomy. This is best described as application of methods to make neurotransmitters and related molecules visible under the microscope in the brain and other tissues. In this way particular nerve pathways can be mapped, and alternations in messenger molecules and their transcript, produced by drugs and other manipulations, can be recorded. In the course of his work he made the major discovery that individual neurons contain more than one neurotransmitter.

Hökfelt's demonstrations that neurotransmitters coexisted in neurons and some neurons contain many different neurotransmitters effectively evoked discussions on the so called Dale's Law and forced rethinking of old ideas and opened up major new vistas on the way the brain works. Dr. Hökfelt is a Foreign Member of the National Academy of Sciences (USA), an honorary member of distinguished scientific societies in many countries, and the recipient of several awards including the Artois-Baillet Latour Health Prize (Brussels), the Bristol-Meyers Award for Distinguished Achievement in Neuroscience Research (New York) and the Grand Medaille, Academie des Sciences (Paris).

Speaker: Dr. Dana Nojima, Senior Application Scientist, PerkinElmer

When: Thursday August 14th, 2008. 1:00 – 2:00pm.

Where: University of Texas Health Science Center – Room 309L
7703 Floyd Curl Drive, San Antonio, TX 78229

For more information on this event, please visit International Cancer Network

The IDD Affymetrix Microarray Core Presents:

A systems biology approach towards genomics: Integration of genotyping, copy number, and expression profiling.
Integrating genomic data has proven to be an effective means of achieving focused discovery and faster validation in genomic studies. The use of whole transcript expression profiling combined with high density SNP and copy number analysis creates a powerful integrated solution for unlocking the genome. It is now possible to study SNP, copy number, allele-specific copy number, loss of heterozygosity, gene level expression, exon level expression, and alternative splicing data using a single sample and only two arrays—the Exon 1.0 ST Array and the SNP Array 6.0. Additionally, ChIP-on-chip assays can be used to integrate epigenetic information and new Gene 1.0 ST Arrays allow for a cost-effective whole transcript analysis. This seminar will feature information for using an integrated genomics approach, including a review of published literature that demonstrates the benefits of this approach.

Presented by: Anthony Green, Genomics Specialist, Affymetrix, Inc.

Wednesday, July 16
Medical School Building, 4th Floor, Room 444B
3:00 – 4:00pm

Refreshments will be served.

For more information contact:
Jim Courage at courage@uthscsa.edu
The Cancer Therapy and Research Center Institute for Drug Development at The University of Texas Health Science Center at San Antonio

See What You’ve Been Missing: TSA™ (Tyramide Signal Amplification) Technology for immunocytochemistry and in situ hybridization. Hosted by Dawn Woods
of PerkinElmer LAS.

We are now six months into the merger between the CTRC and the Health Science Center. I thank the many CTRC staff whose dedication, loyalty, and hard work are helping us through the transition. Thanks also to the many Health Science Center staff who have helped with the myriad of issues that arose during the merger, and to the CTRC Foundation for its significant financial support. The unwavering support for the CTRC from the Health Science Center leadership is another ingredient in our recipe for success.

The CTRC is a cancer center, but what does that mean to the patients that it serves? Is a cancer center simply where patients go to get treated for cancer? After all, any facility offering cancer care can call itself a cancer center if it so chooses, regardless of its quality of care, whether or not its treatments are the best available, and whether or not it undertakes cancer-related research. However, some cancer centers have much more to offer, and the CTRC is in this latter category.

Mark your calendars for a special research seminar this month to be presented by K. Gus Kousoulas, PhD, of Louisiana State University. Dr. Kousoulas is the Mary Louise Martin Professor of Virology and Biotechnology, Director of the Division of Biotechnology and Molecular Medicine, and Director of the LSU-Tulane NIH Center in Experimental Infectious Disease Research at the LSU School of Veterinary Medicine in Baton Rouge. His topic will be “The herpes simplex fusion machine and oncolytic virotherapy.”

This seminar will take place Thursday, June 26, at noon, in 409L MED. Pizza will be served.

This seminar is jointly sponsored by the Departments of Pediatrics (Research) and Microbiology.

Thank you.

On behalf of

Anthony Infante, MD, PhD, Vice-Chair for Research, Department of Pediatrics

Santanu Bose, PhD, Assistant Professor, Department of Microbiology

The 2008 San Antonio Breast Cancer Symposium (SABCS) will be the first Symposium presented by the CTRC, AACR, and the Baylor College of Medicine. The driving force behind the new collaboration is the shared mission of the organizations to advance progress against breast cancer. By combining their respective strengths, the 2008 San Antonio Breast Cancer Symposium will encompass the full spectrum of breast cancer research and facilitate the rapid transition of new knowledge into improved care for breast cancer patients.

Paul Meltzer, MD, Ph.D.
Head, Molecular Genetics Section
Branch Chief, Genetics Branch
National Cancer Institute

DRUG DEVELOPMENT LECTURE SERIES

Invites you to attend a lecture:

“Adult Glioblastoma: Strategies, Challenges and Opportunities”

Presented by

Marc Chamberlain, MD
Professor of Neurology & Neurological Surgery in the Department of Neurology & Neurological Surgery and Chief of the Division of Neuro-Oncology at the University of Washington in Seattle, Washington.